Improvement of post-hypoxic action myoclonus with levetiracetam add-on therapy: A case report
Introduction. Chronic post-anoxic myoclonus, also known as Lance-Adams syndrome, may develop following hypoxic brain injury, and is resistant to pharmacological therapy. Case report. The patient we presented developed post-anoxic action myoclonus with severe, completely incapacitating myocl...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
2014-01-01
|
| Series: | Vojnosanitetski Pregled |
| Subjects: | |
| Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2014/0042-84501405515B.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Introduction. Chronic post-anoxic myoclonus, also known as Lance-Adams
syndrome, may develop following hypoxic brain injury, and is resistant to
pharmacological therapy. Case report. The patient we presented developed
post-anoxic action myoclonus with severe, completely incapacitating myoclonic
jerks. Myoclonus did not respond to the treatment with commonly used agents,
i.e. valproate and clonazepam alone or in combination. Improvement of the
action myoclonus was observed only after adding levetiracetam. Conclusion.
Although Lance-Adams syndrome may not be fully curable at this point,
levetiracetam appears to be a promising agent that can significantly improve
functional level and overall quality of life of patients with this disorder. |
|---|---|
| ISSN: | 0042-8450 |